Biggest News Aggregation in the World
📰 Important Safety News

Page 3 - Important Safety News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Important Safety. Real-time updates on events, politics, business and more.

Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome

IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centresBOSTON, May 22, 2024 -- Rhythm...
United Kingdom United States Northern Ireland Yann Mazabraud David Connolly Philip Beales

Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ?IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome

IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centresBOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals
United Kingdom Northern Ireland United States Adam Daley Philip Beales Yann Mazabraud

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis

JERSEY CITY, N.J., May 21, 2024 /PRNewswire/ -- Celltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and
New Jersey United States Thomas Nusbickel Sarah Amundsen Jeanf Colombel Brucee Sands

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science